Almost all pollinosis patients challenged with an allergen demonstrate an increase in exhaled nitric oxide lasting at least 72 hours

E. Swiebocka, P. Siergiejko, G. Siergiejko, Z. Siergiejko (Bialystok, Poland)

Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I
Session: Airway regulation, provocation and monitoring I
Session type: Thematic Poster Session
Number: 2177
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Swiebocka, P. Siergiejko, G. Siergiejko, Z. Siergiejko (Bialystok, Poland). Almost all pollinosis patients challenged with an allergen demonstrate an increase in exhaled nitric oxide lasting at least 72 hours. Eur Respir J 2007; 30: Suppl. 51, 2177

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Similar levels of nitric oxide in exhaled air in asthma and rhinitis after bronchial allergen challenge
Source: Eur Respir J 2001; 18: Suppl. 33, 269s
Year: 2001

High levels of fractional exhaled nitric oxide (FeNO) only reflect the degree of allergen sensitization in mild childhood asthma
Source: Annual Congress 2005 - Monitoring paediatric asthma
Year: 2005


Latex allergen exposure increases exhaled nitric oxide in symptomatic healthcare workers
Source: Eur Respir J 2005; 25: 309-316
Year: 2005



The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 281s
Year: 2005

The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010

Exposure to ozone does not increase exhaled nitric oxide (FENO) in healthy human volunteers
Source: Annual Congress 2007 - Acute and chronic effects of air pollution
Year: 2007


Nitric oxide levels in exhaled air of children with mild-intermittent asthma sensitized to alternaria
Source: Eur Respir J 2004; 24: Suppl. 48, 596s
Year: 2004

Measurement of exhaled nitric oxide in rhinitic patients outside the pollen season
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008


By how much can exhaled nitric oxide vary over three months in children with stable asthma?
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019

Exhaled nitric oxide and bronchial responsiveness in healthy subjects exposed to organic dust
Source: Eur Respir J 2002; 20: 426-431
Year: 2002



Exhaled nitric oxide in specific challenge tests to assess occupational asthma
Source: Eur Respir J 2002; 20: 1532-1537
Year: 2002



The influence of spirometry on the level of exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 569s
Year: 2003

The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients
Source: Eur Respir J 2004; 24: Suppl. 48, 304s
Year: 2004

The effect of antioxidant therapy on nitric oxide metabolites in exhaled breath condensate in patients with pollen allergy and bronchial asthma
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III
Year: 2007


Nitric oxide metabolites in exhaled breath condesate in patients with pollen allergy and bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 259s
Year: 2004

Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007


The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


Exhaled nitric oxide (FENO) in the assessment of the safety of allergen immunotherapy (SIT) in asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 209s
Year: 2006

Concordant reductions in total IgE and exhaled nitric oxide during oral steroid withdrawal in severe asthma at high altitude
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


The impact of diurnal variations, atopy, pollen exposure and pharmacotherapy on exhaled nitric oxide levels
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011